Risk factors and outcome of COVID-19 in patients with hematological malignancies

BACKGROUND: Prognostic factors of poor outcome in patients with hematological malignancies and COVID-19 are poorly defined. PATIENTS AND METHODS: This was a Spanish transplant group and cell therapy (GETH) multicenter retrospective observational study, which included a large cohort of blood cancer p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Exp Hematol Oncol
Asıl Yazarlar: Piñana, José Luis, Martino, Rodrigo, García-García, Irene, Parody, Rocío, Morales, María Dolores, Benzo, Gonzalo, Gómez-Catalan, Irene, Coll, Rosa, De La Fuente, Ignacio, Luna, Alejandro, Merchán, Beatriz, Chinea, Anabelle, de Miguel, Dunia, Serrano, Ana, Pérez, Carmen, Diaz, Carola, Lopez, José Luis, Saez, Adolfo Jesús, Bailen, Rebeca, Zudaire, Teresa, Martínez, Diana, Jurado, Manuel, Calbacho, María, Vázquez, Lourdes, Garcia-Cadenas, Irene, Fox, Laura, Pimentel, Ana I., Bautista, Guiomar, Nieto, Agustin, Fernandez, Pascual, Vallejo, Juan Carlos, Solano, Carlos, Valero, Marta, Espigado, Ildefonso, Saldaña, Raquel, Sisinni, Luisa, Ribera, Josep Maria, Jimenez, Maria Jose, Trabazo, Maria, Gonzalez-Vicent, Marta, Fernández, Noemí, Talarn, Carme, Montoya, Maria Carmen, Cedillo, Angel, Sureda, Anna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445734/
https://ncbi.nlm.nih.gov/pubmed/32864192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-020-00177-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller